WeVote
Log In

Bill

Bill

S 754

An Act relative to the diagnosis and treatment of autism spectrum disorder

194th Legislature (2025-2026) Introduced by Dylan Fernandes

Massachusetts bill improving autism spectrum disorder diagnosis and treatment access, likely through insurance coverage requirements or state funding mechanisms.

Hearing scheduled for 10/08/2025 from 10:30 AM-02:30 PM in Gardner Auditorium
0
WeVote Research Nonpartisan
Bill Summary · S 754

Legislative bill overview

S 754 is a Massachusetts bill focused on improving the diagnosis and treatment of autism spectrum disorder (ASD). The bill was referred to the Financial Services Committee, suggesting it likely addresses insurance coverage, funding mechanisms, or financial barriers related to autism diagnosis and treatment services.

Why is this important

Autism spectrum disorder affects a significant portion of the population, and access to timely diagnosis and evidence-based treatment can substantially improve outcomes for individuals and reduce long-term healthcare costs. The Financial Services Committee referral indicates the bill probably addresses insurance coverage gaps or affordability issues that currently prevent many Massachusetts residents from accessing needed services.

Potential points of contention

  • Insurance mandate costs: Requiring insurers to cover autism diagnosis and treatment services may increase premiums or reduce coverage in other areas, creating friction between patient advocates and insurance industry representatives
  • Scope of covered treatments: Determining which treatments qualify as medically necessary (ABA therapy, speech therapy, occupational therapy, etc.) is contentious, as coverage decisions affect both accessibility and costs
  • Waiver program funding: If the bill expands state-funded autism services through MassHealth or similar programs, it may require significant new appropriations that compete with other budget priorities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.